Altium Capital Management LP Portfolio Holdings

Altium Capital Management LP

  • $29.1 Million
  • Q1 2025

Altium Capital Management LP has filed its 13F form on May 12, 2025 for Q1 2025 where it was disclosed a total value porftolio of $29.1 Million distributed in 24 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Kempharm, Inc with a value of $6.36M, Evolus, Inc. with a value of $3.56M, Xtant Medical Holdings, Inc. with a value of $3.41M, Profound Medical Corp. with a value of $2.1M, and Xenon Pharmaceuticals Inc. with a value of $2.02M.

Altium Capital Management LP is based out at New York, NY

Below you can find more details about Altium Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $29.1 Million
Healthcare: $28.7 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$170M
$6.36 Million 21.87% of portfolio
1,287,333
Q1 2025 Reduced 30.41%
$561M
$3.56 Million 12.25% of portfolio
296,193
Q1 2025 Reduced 56.76%
$74.7M
$3.41 Million 11.72% of portfolio
7,252,998
Q1 2025 Reduced 2.19%
$102M
$2.1 Million 7.21% of portfolio
360,589
Q1 2025 Reduced 25.65%
$1.84B
$2.02 Million 6.95% of portfolio
60,251
Q1 2025 Reduced 79.08%
$74.9M
$1.66 Million 5.7% of portfolio
1,050,369
Q1 2025 Reduced 26.44%
$141M
$881,000 3.03% of portfolio
303,949
Q1 2025 Reduced 82.06%
$127M
$714,000 2.46% of portfolio
1,051,379
Q1 2025 Reduced 64.95%
$85.7M
$587,000 2.02% of portfolio
273,204
Q1 2025 Reduced 45.9%
$0
$401,000 1.38% of portfolio
574,248
Q1 2025 Reduced 1.23%
$34.1M
$324,000 1.11% of portfolio
123,256
Q1 2025 Reduced 60.24%
Skye Bioscience Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 20.56%
Sunshine Biopharma Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Sharps Technology Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 78.42%
Logicmark Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 94.51%
Karyopharm Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 New
Contineum Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 9.02%
Better Choice CO Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 67.09%
Avadel Pharmaceuticals PLC
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 7.37%
Anteris Technologies Global
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 77.12%
Alpha Cognition Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 35.49%

Summary

  • Portfolio
  • No. of Stocks 24
  • Current Value $29.1 Million
  • Prior Value $29.1 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 12, 2025
  • Form Type 13F-HR/A
  • Activity in Q1 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email